Quercetin Loaded Nanostructured Lipid Carriers-based Gel for Rheumatoid Arthritis: Formulation, Characterization and in vivo Evaluation
DOI:
https://doi.org/10.37285/ijpsn.2018.11.1.4Abstract
Present research work describes the development of potential topical treatment containing nanostructured lipid carriers (NLCs) for rheumatoid arthritis (RA). Quercetin (QCT) is a renowned flavonol useful as model drug for carriers. QCT loaded NLCs were prepared and evaluated for particle size distribution, polydispersity index, zeta potential analysis, in vitro drug release study. Ex vivo study was carried out to evaluate the effect of NLCs on cell proliferation (HIG-82 cell line) and inflammation (TNF-α induction in RAW264.7 cells). The QCT-NLCs showed mean particle size of 155.6 ± 1.8 nm and polydispersity index (PDI) was 0.236 ± 0.4, entrapment efficiency of 95.63 ± 0.14 % and zeta potential of -27 ± 1.2 mV. For the ease of application, NLCs were incorporated into the gel base and final formulation was evaluated for rheological study, texture profile, drug release and antiarthritic activity. QCT-NLC gel showed pseudo plastic flow behavior with excellent texture profile parameters. In vitro drug release studies showed that, QCT-NLC gel has more prominent permeation profile as compared with QCT-loaded gel. In vivo activity was carried out using Complete Freund's adjuvant (CFA) induced arthritic model. Evaluation of the severity of rheumatoid arthritis was done by measurements of hind paw volume, arthritis score and haematological parameters such as rheumatoid factor (RF), C-reactive protein (CRP), red blood cells (RBCs), white blood cells (WBCs), erythrocyte sedimentation rate (ESR) and hemoglobin (Hb). Edema and erythema were not observed after administration of QCT-NLC- gel on the rat skin. In conclusion, the results of in vitro and ex vivo studies, QCT-NLC gel appears a viable formulation system for topical delivery of QCT in the treatment of RA.
Downloads
Metrics
Keywords:
Quercetin, Nanostructured lipid carriers, Rheumatoid arthritis, HIG-82
Downloads
Published
How to Cite
Issue
Section
References
Araujo J, Gonzalez-Mira E, Egea MA, Garcia ML and Souto EB (2010). Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm 393: 167-175.
Bhalekar MR, Upadhaya PG, Nalawade SD, Madgulkar AR and Kshirsagar SJ (2015). Anti-rheumatic activity of chloroquine-SLN gel on wistar rats using complete freund's adjuvant (CFA) model. Ind J Rheumatology 10: 58-64.
Bose S, Du Y, Takhistov P and Michniak-Kohn B (2013). Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. Int J Pharm 441: 56-66.
Choy E (2012). Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 51: v3-v11.
Foegeding EA, Daubert CR, Drake MA, Essick G, Trulsson M, Vinyard CJ and Van De Velde F (2011). A comprehensive approach to understanding textural properties of semi- and soft-solid foods. J Texture Stud 42: 103-129.
Gugler R, Leschik M and Dengler HJ (1975). Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9: 229-234.
ICH Harmonised Tripartite Guideline (2003). "Stability testing of new drug substances and products." Q1A (R2), current step 4 version
Han F, Yin R, Che X, Yuan J, Cui Y, Yin H and Li S (2012). Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. Int J Pharm 439: 349-357.
Hongtao Li and Xiaochen GU (2007). Correlation between drug dissolution and polymer hydration: A study using texture analysis. Int J Pharm 342: 18-25.
Iqbal MA, Md S, Sahni JK, Baboota S, Dang S and Ali J (2012). Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target 20: 813-830.
Jackson JK, Higo T, Hunter WL and Burt HM (2006). The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflammation Res 55: 168-175.
Jeoung BR, Lee KD, Na CS, Kim YE, Kim B and Kim YR (2013). Ganghwaljetongyeum, an anti-arthritic remedy, attenuates synoviocyte proliferation and reduces the production of proinflammatory mediators in macrophages: the therapeutic effect of GHJTY on rheumatoid arthritis. BMC Complementary Altern Med 13: 47.
Jeyadevi R, Sivasudha T, Rameshkumar A, Ananth DA, Aseervatham GSB, Kumaresan K, and Renganathan R (2013). Enhancement of anti arthritic effect of quercetin using thioglycolic acid-capped cadmium telluride quantum dots as nanocarrier in adjuvant induced arthritic Wistar rats. Colloids Surf B 112: 255-263.
Jones DS, Woolfson AD, Djokic J and Coulter WA (1996). Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res 13: 1734-1738.
Joshi MD and Müller RH (2009). Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 71(2): 161-172.
Kaul TN, Middleton E and Ogra PL (1985). Antiviral effect of flavonoids on human viruses. J Med Virol 15(1): 71-79.
Kaur G and Sultana S (2012). Evaluation of antiarthritic activity of isoeugenol in adjuvant induced arthritis in murine model. Food Chem Toxicol 50(8): 2689-2695.
Khaled KA, El-Sayed YM and Al-Hadiya BM (2003). Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev Ind Pharm 29(4): 397-403.
Lau MH, Tang J and Paulson AT (2000). Texture profile and turbidity of gellan/gelatin mixed gels. Food Res Int 33: 665-671.
Li H and Gu X (2007). Correlation between drug dissolution and polymer hydration: a study using texture analysis. Int J Pharm 342 (1-2): 18-25.
Li H, Zhao X, Ma Y, Zhai G, Li L and Lou H (2009). Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Controlled Release 133(3): 238-244.
Madane RG and Mahajan HS (2016). Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization and in vivo study. Drug Delivery 23(4): 1326-1334.
McInnes IB and Schett G (2007). Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7(6): 429-442.
Montenegro L, Campisi A, Sarpietro MG, Carbone C, Acquaviva R, Raciti G and Puglisi G (2011). In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug Dev Ind Pharm 37(6): 737-746.
Müller RH, Radtke M and Wissing SA (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242(1-2): 121-128.
Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T and Barzegar-Jalali M (2003). The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 250(2): 359-369.
Patil KR, Patil CR, Jadhav RB, Mahajan VK, Patil PR and Gaikwad PS (2011). Anti-Arthritic Activity of Bartogenic Acid Isolated from Fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evidence-Based Complementary Altern Med
Pons M and Fiszman SM (1996). Instrumental texture profile analysis with particular reference to gelled systems. J Texture Stud 27: 597-624.
Rao MK and B Ghosh (1999). Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages. Int J Immunopharmacol, 21(7): 435-443.
Sharma S, Sahu D, Das HR and Sharma D (2011). Amelioration of collagen-induced arthritis by Salix nigra bark extract via suppression of pro-inflammatory cytokines and oxidative stress. Food Chem Toxicol, 49(12): 3395-3406.
Scott DL (2000). Prognostic factors in early rheumatoid arthritis. Rheumatology, 39: 24-29.
Zhang X, Lu J, Qiao H, Liu H, Ni J, Zhang W and Shi Y (2010). Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology, Powder Technol, 197: 120-128.
Williams AC and Barry BW (1991).Terpenes and lipid protein partitioning theory of skin permeation enhancement. Pharm Res 8: 17-24.
